Medicine for treating hyperlipemia

Abstract

Disclosed is a Chinese medicinal preparatoinfor treating hyperlipemia, which is prepared from Chinese medicinal herbs including (by weight ratio), ligustrum japonicum 15-30%, root of japanese thistle 10-20%, white atractylodes rhizome 5-20%, radix salvia miltiorrhiza 5-20%, eucommia bark 5-15%, and Buddha's hand 5-15%.

Description

technical field [0001] The invention belongs to medical preparations derived from plant materials, in particular to a traditional Chinese medicine preparation for treating hyperlipidemia. Background technique [0002] Hyperlipidemia is a common and frequently-occurring disease, and the detection rate of men and women is about 11.6% and 18.2% respectively. Hyperlipidemia is closely related to hypertension, hyperglycemia and aging, and is most closely related to the incidence of coronary heart disease. According to a survey by the World Health Organization, 75% of people in the world are in a sub-healthy state, such as hyperlipidemia, high blood pressure, high blood sugar, high body weight and low immune function. Therefore, effective control of hyperlipidemia It is of great practical significance to treat hyperlipidemia and even cure hyperlipidemia. [0003] At present, there are synthetic drugs for effectively controlling hyperlipidemia and treat...

AI Technical Summary

Problems solved by technology

Although the above-mentioned lipid-lowering drugs can achieve good results in a short period of time, there are still many problems to be explored and solved: ①After the lipid-lowering target is reached, once the drug is stopped, the curative effect is difficult to stabilize and consolidate, and even a vicious rebound in blood lipid levels occurs ; ②Lipid-lowering drugs often cause gastrointestinal discomfort in clinical application, such as abdominal pain, constipation, flatulence, nausea, vomiting, diarrhea, indigestion, loss of appetite and other adverse reactions, in addition, liver and kidney function and granulocyte count are prone to occur ③Sharp lipid-lowering can easily induce senile mental and emotional changes or sudden cardiovascular and cerebrovascular events; ④Premenopausal women are prone to endocrine disorders after lipid-lowering treatment, while postmenopausal women are prone to endocrine disorders due to lipid-lowering treatment. Symptoms of secretion disorders further aggravated

There are still some deficiencies in the above-mentioned drugs. There is a lack of unified standards for clinical research on the treatment of hyperlipidemia with traditional Chinese medicine, such as inconsistent case selection, curative effect determination, and control group settings. Or side effects, or long-term use to produce drug tolerance and other disadvantages